Part 7/10:
The neurotechnology realm historically includes steep financial burdens for new entrants wishing to develop BCIs, often requiring over $100 million in funding for a startup. However, Science Corporation aims to alleviate this burden by offering three essential tools—probes, software, and headstages—thus lowering the cost of entry to less than $5 million.
This reduction opens opportunities for startups to jumpstart their BCI developments without the astronomical initial investments that have historically hindered innovation.
The technical workings of BCIs combine sophisticated software and innovative hardware designs. Science Corporation’s proprietary software called Synapse allows users to manage and analyze neural data efficiently, turning complex signals into interpretable formats.